Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

Smoking and prostate cancer: a life course analysis

Authors: Evelyn Jiménez-Mendoza, Ruth A. Vázquez-Salas, Tonatiuh Barrientos-Gutierrez, Luz Myriam Reynales-Shigematsu, Isaac Roberto Labra-Salgado, Hugo A. Manzanilla-García, Luisa E. Torres-Sánchez

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

Inconsistent associations between smoking status and prostate cancer (PC) could be due to exposure assessment error. Reconstructing smoking behaviors over the life course could reduce exposure assessment error.

Methods

As part of a case-control study, we identified 402 incident and histologically confirmed PC cases that were matched by age (±5 years) to 805 population controls. Through direct interview, we obtained information about: age at smoking onset, intensity and frequency of cigarette smoking at different life stages, and smoking cessation age. Smoking status at interview and average smoking index over the lifetime (packs/year) were estimated. Life course smoking patterns were obtained applying the k-means+ method for longitudinal data to the smoking index (pack/year) for each life stage.

Results

Two life-course smoking patterns were identified among ever smokers: “pattern A” characterized by males who reported low and constant smoking intensity (87.8%), and “pattern B” (12.2%) males with an initial period of low intensity, followed by an increase during the second period. Compared to never smokers, pattern B was associated with higher poorly differentiated PC, (OR 2.30; 95% CI 1.21–4.38). No association was observed with average smoking index.

Conclusion

Life course smoking patterns seem to capture the smoking variability during life course and reduce the likelihood of reverse causation. Using this assessment strategy our findings support the potential role of tobacco smoking in PC, particularly poorly differentiated PC. Prospective studies with comprehensive smoking history during the lifetime are needed to confirm these findings.
Appendix
Available only for authorised users
Literature
1.
go back to reference U.S. Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014. U.S. Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
4.
go back to reference Darlington GA, Kreiger N, Lightfoot N, Purdham J, Sass-Kortsak A. Prostate cancer risk and diet, recreational physical activity and cigarette smoking. Chronic Dis Can. 2007;27:145–53.PubMed Darlington GA, Kreiger N, Lightfoot N, Purdham J, Sass-Kortsak A. Prostate cancer risk and diet, recreational physical activity and cigarette smoking. Chronic Dis Can. 2007;27:145–53.PubMed
5.
go back to reference Bae JM, Li ZM, Shin MH, Kim DH, Lee MS, Ahn YO. Cigarette smoking and prostate cancer risk: negative results of the Seoul male cancer cohort study. Asian Pac J Cancer Prev. 2013;14:4667–9.CrossRefPubMed Bae JM, Li ZM, Shin MH, Kim DH, Lee MS, Ahn YO. Cigarette smoking and prostate cancer risk: negative results of the Seoul male cancer cohort study. Asian Pac J Cancer Prev. 2013;14:4667–9.CrossRefPubMed
6.
go back to reference Giovannucci E, Rimm EB, Ascherio A, Colditz GA, Spiegelman D, Stampfer MJ, et al. Smoking and risk of total and fatal prostate cancer in United States health professionals. Cancer Epidemiol Biomark Prev. 1999;8:277–82. Giovannucci E, Rimm EB, Ascherio A, Colditz GA, Spiegelman D, Stampfer MJ, et al. Smoking and risk of total and fatal prostate cancer in United States health professionals. Cancer Epidemiol Biomark Prev. 1999;8:277–82.
7.
go back to reference Lotufo PA, Lee IM, Ajani UA, Hennekens CH, Manson JE. Cigarette smoking and risk of prostate cancer in the physicians’ health study (United States). Int J Cancer. 2000;87:141–4.CrossRefPubMed Lotufo PA, Lee IM, Ajani UA, Hennekens CH, Manson JE. Cigarette smoking and risk of prostate cancer in the physicians’ health study (United States). Int J Cancer. 2000;87:141–4.CrossRefPubMed
8.
go back to reference Lund Nilsen TI, Johnsen R, Vatten LJ. Socio-economic and lifestyle factors associated with the risk of prostate cancer. Br J Cancer. 2000;82:1358–63.CrossRefPubMed Lund Nilsen TI, Johnsen R, Vatten LJ. Socio-economic and lifestyle factors associated with the risk of prostate cancer. Br J Cancer. 2000;82:1358–63.CrossRefPubMed
9.
go back to reference Rohrmann S, Genkinger JM, Burke A, Helzlsouer KJ, Comstock GW, Alberg AJ, Platz EA. Smoking and risk of fatal prostate cancer in a prospective U.S. study. Urology. 2007;69:721–5.CrossRefPubMedPubMedCentral Rohrmann S, Genkinger JM, Burke A, Helzlsouer KJ, Comstock GW, Alberg AJ, Platz EA. Smoking and risk of fatal prostate cancer in a prospective U.S. study. Urology. 2007;69:721–5.CrossRefPubMedPubMedCentral
11.
go back to reference Giles GG, Severi G, McCredie MR, English DR, Johnson W, Hopper JL, et al. Smoking and prostate cancer: findings from an Australian case-control study. Ann Oncol. 2001;12:761–5.CrossRefPubMed Giles GG, Severi G, McCredie MR, English DR, Johnson W, Hopper JL, et al. Smoking and prostate cancer: findings from an Australian case-control study. Ann Oncol. 2001;12:761–5.CrossRefPubMed
12.
go back to reference Plaskon LA, Penson DF, Vaughan TL, Cigarette SJL. Smoking and risk of prostate cancer in middle-aged men. Cancer Epidemiol Biomark Prev. 2003;12:604–9. Plaskon LA, Penson DF, Vaughan TL, Cigarette SJL. Smoking and risk of prostate cancer in middle-aged men. Cancer Epidemiol Biomark Prev. 2003;12:604–9.
13.
go back to reference Sharpe CR, Siemiatycki J. Joint effects of smoking and body mass index on prostate cancer risk. Epidemiology. 2001;12:546–51.CrossRefPubMed Sharpe CR, Siemiatycki J. Joint effects of smoking and body mass index on prostate cancer risk. Epidemiology. 2001;12:546–51.CrossRefPubMed
18.
go back to reference Genolini C, Alacoque X, Sentenac M, Arnaud C. kml and kml 3d: R packages to cluster longitudinal data. J Stat SOFT. 2015;65:1–34.CrossRef Genolini C, Alacoque X, Sentenac M, Arnaud C. kml and kml 3d: R packages to cluster longitudinal data. J Stat SOFT. 2015;65:1–34.CrossRef
22.
go back to reference English KM, Pugh PJ, Parry H, Scutt NE, Channer KS, Jones TH. Effect of cigarette smoking on levels of bioavailable testosterone in healthy men. Clin Sci (Lond). 2001;100:661–5.CrossRef English KM, Pugh PJ, Parry H, Scutt NE, Channer KS, Jones TH. Effect of cigarette smoking on levels of bioavailable testosterone in healthy men. Clin Sci (Lond). 2001;100:661–5.CrossRef
24.
go back to reference Prezioso D, Denis LJ, Klocker H, Sciarra A, Reis M, Naber K, et al. Estrogens and aspects of prostate disease. Int J Urol. 2007;14:1–16.CrossRefPubMed Prezioso D, Denis LJ, Klocker H, Sciarra A, Reis M, Naber K, et al. Estrogens and aspects of prostate disease. Int J Urol. 2007;14:1–16.CrossRefPubMed
26.
go back to reference Fowles J, Dybing E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob Control. 2003;12:424–30.CrossRefPubMedPubMedCentral Fowles J, Dybing E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob Control. 2003;12:424–30.CrossRefPubMedPubMedCentral
31.
go back to reference Encuesta Nacional de Salud y Nutrición (ENSANUT) 2012. Resultados por entidad federativa, Distrito Federal. México: Instituto Nacional de Salud Pública; 2013. p. 49–50. Encuesta Nacional de Salud y Nutrición (ENSANUT) 2012. Resultados por entidad federativa, Distrito Federal. México: Instituto Nacional de Salud Pública; 2013. p. 49–50.
32.
go back to reference Reynales Shigematsu LM, Shamah Levy T, Méndez Gómez-Humarán I, Rojas Martínez R, Lazcano Ponce E. Encuesta Global de Tabaquismo en Adultos. México 2009. Organización Panamericana de la Salud; Instituto Nacional de Salud Pública (MX). Cuernavaca (México): Instituto Nacional de Salud Pública, 2010. Coeditado con la Organización Panamericana de la Salud, 2010. Reynales Shigematsu LM, Shamah Levy T, Méndez Gómez-Humarán I, Rojas Martínez R, Lazcano Ponce E. Encuesta Global de Tabaquismo en Adultos. México 2009. Organización Panamericana de la Salud; Instituto Nacional de Salud Pública (MX). Cuernavaca (México): Instituto Nacional de Salud Pública, 2010. Coeditado con la Organización Panamericana de la Salud, 2010.
33.
go back to reference Zhu K, McKnight B, Stergachis A, Daling JR, Levine RS. Comparison of self-report data and medical records data: results from a case-control study on prostate cancer. Int J Epidemiol. 1999;28:409–17.CrossRefPubMed Zhu K, McKnight B, Stergachis A, Daling JR, Levine RS. Comparison of self-report data and medical records data: results from a case-control study on prostate cancer. Int J Epidemiol. 1999;28:409–17.CrossRefPubMed
34.
go back to reference World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC: AICR; 2007. p. 305–9. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC: AICR; 2007. p. 305–9.
Metadata
Title
Smoking and prostate cancer: a life course analysis
Authors
Evelyn Jiménez-Mendoza
Ruth A. Vázquez-Salas
Tonatiuh Barrientos-Gutierrez
Luz Myriam Reynales-Shigematsu
Isaac Roberto Labra-Salgado
Hugo A. Manzanilla-García
Luisa E. Torres-Sánchez
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4065-7

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine